surmount 1 tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight SURMOUNT-1

Glucagon-like peptide-1 ( GLP-1 ): released later in a meal to regulate blood sugar and appetite

Despite likely being a similar tier as GLP-1 RAs and SGLT2is for many patient insurances, this elevated AWP is important to note for patients with co-insurances, deductibles, the Medicare coverage gap, patients without insurance, and for the total cost of healthcare

Starting dose for Semaglutide: 0.25 mg weekly = 5 units (0.05 mL) on the insulin syringe provided

Figure 3 : Left (SURMOUNT I): weight reduction of 5%, 10%, 15%, 20%, and 25% or more at week 72 with tirzepatide 5mg, 10mg, and 15mg versus placebo

Movement matters too

PlexusDx Compounded Tirzepatide Injection starts at $249/month with no insurance required